Rhythm Pharmaceuticals (RYTM) News Today → Elon Musk Secret Crypto Plot Exposed (From Crypto 101 Media) (Ad) Free RYTM Stock Alerts $38.31 -0.19 (-0.49%) (As of 12:51 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMario Lemieux Foundation presents AHN with $5 million gift to establish Mario Lemieux Center for Heart Rhythm Caremsn.com - May 9 at 8:20 PMLeon Talks Transformative Portrayal of Blues Legend Eddie Taylor in ‘The Rhythm and the Blues’ | EUR Exclusivemsn.com - May 9 at 3:19 PMNational Bank of Canada FI Boosts Stake in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)marketbeat.com - May 9 at 7:08 AMB of A Securities Downgrades Rhythm Pharmaceuticals (RYTM)msn.com - May 9 at 5:18 AMNeedham & Company LLC Lowers Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target to $46.00americanbankingnews.com - May 9 at 4:22 AMSpin Rhythm XD - Official VR & PlayStation Launch Trailermsn.com - May 8 at 7:17 PMSteady Performance and Promising European Growth Justify Buy Rating for Rhythm Pharmaceuticalsmarkets.businessinsider.com - May 8 at 7:17 PMMaintaining Buy Rating on Rhythm Pharmaceuticals: Positive Outlook Amidst Growth and Upcoming Catalystsmarkets.businessinsider.com - May 8 at 7:17 PMRhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q1 2024 Earnings Call Transcriptfinance.yahoo.com - May 8 at 7:17 PMRhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives Average Recommendation of "Moderate Buy" from Brokeragesmarketbeat.com - May 8 at 3:16 PMRhythm Pharmaceuticals (NASDAQ:RYTM) PT Lowered to $79.00marketbeat.com - May 8 at 2:34 PMRhythm Pharmaceuticals (NASDAQ:RYTM) Posts Earnings Results, Misses Expectations By $0.01 EPSmarketbeat.com - May 8 at 8:41 AMRhythm Pharmaceuticals Inc (RYTM) Q1 2024 Earnings Call Transcript Highlights: A Detailed ...finance.yahoo.com - May 8 at 8:08 AMRhythm Pharmaceuticals (NASDAQ:RYTM) Lowered to "Neutral" at Bank of Americamarketbeat.com - May 8 at 7:12 AMQ1 2024 Rhythm Pharmaceuticals Inc Earnings Callfinance.yahoo.com - May 8 at 3:08 AMRhythm Pharmaceuticals (NASDAQ:RYTM) Shares Gap Down on Analyst Downgradeamericanbankingnews.com - May 8 at 1:56 AMBuy Rating Affirmed: Rhythm Pharmaceuticals’ Growth and Clinical Advancements Fuel Optimismmarkets.businessinsider.com - May 7 at 4:53 PMBuy Rating Affirmed for Rhythm Pharmaceuticals Amid Positive Prescription Growth and Pipeline Potentialmarkets.businessinsider.com - May 7 at 4:53 PMRYTM Stock Earnings: Rhythm Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024msn.com - May 7 at 4:53 PMThe 3 Best Nasdaq Stocks to Buy in May 2024investorplace.com - May 7 at 2:52 PMRhythm Pharmaceuticals (NASDAQ:RYTM) Given New $46.00 Price Target at Needham & Company LLCmarketbeat.com - May 7 at 2:35 PMMarvelle Healthcare Revolutionizes Hydration with the Debut of Premium Natural Mineral Water Brand, Rhythmmsn.com - May 7 at 11:53 AMRhythm Pharmaceuticals GAAP EPS of -$2.35 misses by $0.33, revenue of $25.97M misses by $0.93Mmsn.com - May 7 at 11:53 AMRhythm Pharmaceuticals Reports Q1 2024 Results: Revenue Growth Amidst Challengesfinance.yahoo.com - May 7 at 11:52 AMRhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Updateglobenewswire.com - May 7 at 7:00 AMRhythm Pharmaceuticals Presents Data from Phase 3 Pediatrics Trial at Pediatric Endocrine Society Annual Meetingfinance.yahoo.com - May 6 at 10:50 AMRhythm Pharmaceuticals (RYTM) Set to Announce Earnings on Tuesdayamericanbankingnews.com - May 5 at 5:36 AMAnMed Rhythm on the River in Powdersville postponed: Here's what you need to knowmsn.com - May 3 at 2:26 PMCelebrate dance with ‘Rhythm and Joy': A Kathak choreography by Shovana Narayanmsn.com - May 2 at 7:13 PMRhythm and Roots Festival's founder, Chuck Wentworth, passes away at 72msn.com - May 2 at 2:12 PMCardiac Monitoring & Cardiac Rhythm Management Devices Market Worth $26.4 billion | MarketsandMarkets™finance.yahoo.com - May 2 at 2:12 PMRhythm Pharmaceuticals (NASDAQ:RYTM) Trading 5.5% Higher marketbeat.com - April 30 at 6:01 PMRhythm Pharmaceuticals (RYTM) Set to Announce Quarterly Earnings on Tuesdaymarketbeat.com - April 30 at 12:16 PM'Bigger than the music': Legendary producer of Rhythm & Roots Festival diesyahoo.com - April 30 at 7:50 AMRhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & Endocrinologyglobenewswire.com - April 29 at 6:30 PMRhythm Pharmaceuticals (NASDAQ:RYTM) Given Buy Rating at Needham & Company LLCmarketbeat.com - April 26 at 8:44 AMWedge Capital Management L L P NC Sells 28,213 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)marketbeat.com - April 25 at 7:47 AMRhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024globenewswire.com - April 24 at 4:01 PMFederated Hermes Inc. Reduces Stock Holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)marketbeat.com - April 19 at 8:27 AMRhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Cut to $52.00 by Analysts at Wells Fargo & Companymarketbeat.com - April 18 at 9:13 AMRhythm Pharmaceuticals Announces New Employment Inducement Grantsglobenewswire.com - April 16 at 4:01 PMMarket Sentiment Around Loss-Making Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)finance.yahoo.com - April 14 at 10:32 AMRhythm and Autism comes to Fertile Ground Festivalyahoo.com - April 11 at 12:32 PM5 Analysts Assess Rhythm Pharmaceuticals: What You Need To Knowmarkets.businessinsider.com - April 10 at 4:29 PMLee Brice coming to Rhythm City Casinomsn.com - April 10 at 11:29 AMHendersonville's 2024 Rhythm and Brews lineup announcedmsn.com - April 9 at 7:47 AMRising Chorus: Rachana Shah and Rhythm Wagholikar’s Anthem for Prime Minister Modimsn.com - April 8 at 7:51 AMSG Americas Securities LLC Decreases Stock Position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)marketbeat.com - April 8 at 4:09 AMVanguard Group Inc. Grows Holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)marketbeat.com - April 7 at 4:10 AMHeadbangers: Rhythm Royale - Official Battle of the Dancers & Season 3 Launch Trailermsn.com - April 4 at 2:32 PM Get Rhythm Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RYTM and its competitors with MarketBeat's FREE daily newsletter. Email Address Biggest hedge fund manager has huge warning for U.S. dollar (Ad)Prescient CEO Makes Shocking New Prediction Known for his eerily accurate market calls over the years, this CEO has just revealed his newest prediction about "America's New Money." Get the details before it's taken offline. RYTM Media Mentions By Week RYTM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RYTM News Sentiment▼0.120.45▲Average Medical News Sentiment RYTM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RYTM Articles This Week▼336▲RYTM Articles Average Week Get Rhythm Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RYTM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Avidity Biosciences News Today PTC Therapeutics News Today Indivior News Today Vera Therapeutics News Today Arvinas News Today Geron News Today Dyne Therapeutics News Today Maravai LifeSciences News Today Corcept Therapeutics News Today Ardelyx News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RYTM) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis 1 Biotech Stock has been shocking the marketsHuge AlertsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rhythm Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
